Camlin Fine Sciences share news and announcements
NSE: CAMLINFINEBSE: 532834Chemicals & PetrochemicalsSmall Cap
Last close ₹80.53down ₹3.23 (3.86%)BSE ₹80.36
Share price at the NSE close on 23 Oct 2026. Previous close ₹83.76.
52-week range of traded prices to 23 Oct 2026
₹78.80Low, 23 Oct 2026₹204.57High, 23 Oct 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹1,547 Cr1,056th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 11 Aug 2026
- 263.0
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹29 crore of one-off items, the largest of them in the quarter to Mar 2026.
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 26 May 2026
- 1.5
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 11 Aug 2026
- 0.6%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹29 crore of one-off items, the largest of them in the quarter to Mar 2026.
- −2.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 11 Aug 2026
- 0.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 26 May 2026
- 0.67
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 7,32,39442.1% delivered
Camlin Fine Sciences share news and announcements
645 announcements, routine notices left out, newest first. Page 2 of 13.
Feb 2026
Jan 2026
8 Jan · Legal
The exchange asked on 7 Jan 2026
7 Jan · Rating
Dec 2025
31 Dec · Legal
24 Dec · General Updates
Nov 2025
28 Nov · General Updates
26 Nov · General Updates
13 Nov · Meeting
5 Nov · Analysts
Oct 2025
17 Oct · General Updates
Sep 2025
29 Sep · Updates
29 Sep · Meeting
29 Sep · Board meeting
25 Sep · Business
12 Sep · Disclosure
Aug 2025
18 Aug · Meeting
8 Aug · Board meeting
5 Aug · Analysts
Jul 2025
17 Jul · General Updates
Jun 2025
25 Jun · Business
23 Jun · Legal
Exchange has sought clarification from Camlin Fine Sciences Limited for the quarter ended 31-Mar-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results submitted in XBRL with discrepancies The response of the Company is awaited.18 Jun · Analysts
May 2025
23 May · Management
15 May · Analysts